Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606
Conditions
- Pulmonary Arterial Hypertension
Interventions
- DRUG: L606 (Liposomal Treprostinil) Inhalation Solution 51ug
- DEVICE: L606 Inhalation System
- OTHER: Placebo Solution
Sponsor
Pharmosa Biopharm Inc.
Collaborators